utility

header_second

RegMed Investors (RMi) went exclusive on July 27th!

Your complimentary subscription to RegMed Investors’ (RMi) reporting on the stem, cell and gene therapy and RegMed sector has expired.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

It’s up to you to choose the level of content access to provide a premium experience and value - don’t wait to exhale!

I also bring fresh perspectives that yield a whole that is greater than the sum of the parts as I convey a spectrum of factors that explain outcomes, analytical principles and analysis without the encumbrance of trading, investment or I-Banking.

So, after these years of following our facts … first and fast; be part of our “inner circle” as a subscriber!

Stay with me and join our coalition and have a seat at the appreciation table!

Login Sign up now Not now

content_top

43 companies, 1 interpreter! Insight, foresight
and recommendation

Closing Bell

content_middle

Closing Bell

content_right

January 25, 2020 - 4:23pm | Closing Bell
RegMed Investors' (RMi) closing bell: which risks are playing-out that haven't already been there?
January 23, 2020 - 5:42pm | Closing Bell
RegMed Investors’ (RMi) closing bell: a negative close, after a positive following a negative close and a holiday
January 22, 2020 - 7:12pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the sector grinds and creeps higher
January 21, 2020 - 7:01pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the cell and gene therapy dived
January 17, 2020 - 7:52pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the sector slips and slides
January 16, 2020 - 6:09pm | Closing Bell
RegMed Investors’ (RMi) closing bell: stability hangs in the balance, 7 positive out of 12 closes have kept the cell and gene therapy sector flinching
January 15, 2020 - 5:16pm | Closing Bell
RegMed Investors’ (RMi) closing bell: am I going deaf?
January 14, 2020 - 6:07pm | Closing Bell
RegMed Investors’ (RMi) closing bell: Dow’s barely up as S&P and NASDAQ dive
January 13, 2020 - 6:38pm | Closing Bell
RegMed Investors’ (RMi) closing bell: day one (1) of JPMorgan and a share pricing downer
January 11, 2020 - 5:45pm | Closing Bell
RegMed Investors’ (RMi) closing bell: as I wrote, the downside slide is starting
January 9, 2020 - 7:28pm | Closing Bell
RegMed Investors’ (RMi) closing bell: many share pricing and valuations are tipping the scales
January 8, 2020 - 6:58pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the sector’s rise defused by lightening of political rhetoric
January 7, 2020 - 6:20pm | Closing Bell
RegMed Investors’ (RMi) closing bell: cell and gene therapy pricing was considered a safe bet on Tuesday
January 6, 2020 - 6:40pm | Closing Bell
RegMed Investors’ (RMi) closing bell: fundamentals evolved in the hours of a session
January 3, 2020 - 7:29pm | Closing Bell
RegMed Investors’ (RMi) closing bell: volatility sets the tone for first two trading sessions post a holiday
January 2, 2020 - 4:59pm | Closing Bell
RegMed Investors’ (RMi) closing bell: starting the year with another downside rotation from Tuesday’s close
December 31, 2019 - 7:13pm | Closing Bell
RegMed Investors’ (RMi) closing bell: It’s over, 2019 ends with sadness and some glee
December 30, 2019 - 6:39pm | Closing Bell
RegMed Investors’ (RMi) closing bell: a ringside seat to share price destruction
December 27, 2019 - 7:38pm | Closing Bell
RegMed Investors’ (RMi) closing bell: another slippery slope and sliding sector as risk defines the investment pattern
December 26, 2019 - 5:32pm | Closing Bell
RegMed Investors’ (RMi) closing bell: the sector tripped after all the good cheer

Pages

footer

© 2015 RegMed Investors (regmedinvestors.com), all rights are reserved.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry MCusker . Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of RegMed Investors (RM-i); who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other RM-i media services or reposting please email hwm@regmedinvestors.com.